Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,900 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,900 | N/A | N/A | N/A | N/A |
| Operating Expenses | 18,882 | 20,041 | 31,089 | 23,039 | 15,988 |
| Operating Income | -16,982 | -20,041 | -31,089 | -23,039 | -15,988 |
| Interest Expense | 0 | 0 | 0 | 462 | 1,166 |
| Other Income | 208 | 668 | 2,041 | 0 | -526 |
| Pre-tax Income | -16,774 | -19,373 | -29,048 | -23,501 | -17,680 |
| Income Tax | -17 | -81 | -1,378 | 253 | 1 |
| Net Income Continuous | -16,757 | -19,292 | -27,670 | -23,754 | -17,681 |
| Net Income | $-16,757 | $-19,292 | $-27,670 | $-23,754 | $-17,681 |
| EPS Basic Total Ops | -2.11 | -10.92 | -157.72 | -522.00 | -933.00 |
| EPS Basic Continuous Ops | -2.10 | -7.54 | -105.61 | -507.56 | -933.53 |
| EPS Diluted Total Ops | -2.11 | -10.92 | -157.72 | -522.00 | -933.00 |
| EPS Diluted Continuous Ops | -2.10 | -7.54 | -105.61 | -507.56 | -933.53 |
| EPS Diluted Before Non-Recurring Items | -2.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-16,700 | $-20,041 | $-21,989 | $-22,781 | $-15,985 |